Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
605.09
500.19
417.63
390.79
458.26
347.79
331.76
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
605.09
500.19
417.63
390.79
458.26
347.79
331.76
Raw Material Cost
162.29
139.56
118.39
117.72
125.51
118.50
87.90
Purchase of Finished goods
0.32
1.54
1.41
4.29
3.77
1.01
1.72
(Increase) / Decrease In Stocks
0.28
0.51
0.33
-0.53
-1.45
0.00
-0.05
Employee Cost
101.99
93.30
81.29
77.86
43.63
39.54
35.35
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
153.26
132.62
112.59
96.09
89.48
68.76
65.29
Total Expenditure (Excl Depreciation)
418.14
367.53
314.01
295.43
260.94
227.81
190.21
Operating Profit (PBDIT) excl Other Income
186.95
132.66
103.62
95.36
197.32
119.98
141.55
Other Income
12.68
10.24
5.88
4.72
27.08
8.79
5.67
Operating Profit (PBDIT)
199.63
142.90
109.50
100.08
224.40
128.77
147.22
Interest
1.28
2.35
3.08
1.68
1.81
0.96
1.47
Exceptional Items
-6.16
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
192.19
140.55
106.42
98.40
222.59
127.81
145.75
Depreciation
44.55
41.49
33.95
27.91
24.25
22.45
23.42
Profit Before Tax
147.92
98.90
72.60
70.98
198.34
105.36
122.33
Tax
34.30
28.94
20.76
19.48
42.85
29.44
32.86
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
113.34
70.12
51.71
51.01
155.49
75.92
89.47
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
113.34
70.12
51.71
51.01
155.49
75.92
89.47
Share in Profit of Associates
0.81
-0.81
0.61
0.85
-0.68
-0.25
0.53
Minority Interest
-0.14
0.32
-0.55
-0.02
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
115.93
69.95
52.99
51.88
154.81
75.67
90.00
Equity Capital
159.16
52.99
52.95
52.93
52.90
52.87
52.84
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
1.81
1.19
2.77
2.77
4.05
6.12
5.19
Operating Profit Margin (Excl OI)
30.9%
26.52%
24.81%
24.4%
43.06%
34.5%
42.67%
Gross Profit Margin
31.76%
28.1%
25.48%
25.18%
48.57%
36.75%
43.93%
PAT Margin
18.73%
14.02%
12.38%
13.05%
33.93%
21.83%
26.97%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 20.97% vs 19.77% in Dec 2024
Consolidate Net Profit
YoY Growth in nine months ended Dec 2025 is 65.73% vs 32.01% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is 40.92% vs 28.03% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is -45.53% vs -23.70% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
Compare Nine Monthly Results Of Thyrocare Tech. With
Figures in Cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
605.09
0
605.09
Other Operating Income
0.00
0.00
0.00
Total Operating income
605.09
0
605.09
Raw Material Cost
162.29
0
162.29
Purchase of Finished goods
0.32
0
0.32
(Increase) / Decrease In Stocks
0.28
0
0.28
Employee Cost
101.99
0
101.99
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
153.26
0.00
153.26
Total Expenditure (Excl Depreciation)
418.14
0
418.14
Operating Profit (PBDIT) excl Other Income
186.95
0.00
186.95
Other Income
12.68
0
12.68
Operating Profit (PBDIT)
199.63
0
199.63
Interest
1.28
0
1.28
Exceptional Items
-6.16
0
-6.16
Gross Profit (PBDT)
192.19
0
192.19
Depreciation
44.55
0
44.55
Profit Before Tax
147.92
0
147.92
Tax
34.30
0
34.30
Provisions and contingencies
0.00
0
0.00
Profit After Tax
113.34
0
113.34
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
113.34
0
113.34
Share in Profit of Associates
0.81
0
0.81
Minority Interest
-0.14
0
-0.14
Other related items
0.00
0.00
0.00
Consolidated Net Profit
115.93
0
115.93
Equity Capital
159.16
0
159.16
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
31.76%
0.00%
0.00
31.76%
PAT Margin
18.73%
0.00%
0.00
18.73%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 605.09 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 20.97% vs 19.77% in Dec 2024
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 115.93 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 65.73% vs 32.01% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 186.95 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 40.92% vs 28.03% in Dec 2024
Nine Monthly - Interest
Interest 1.28 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is -45.53% vs -23.70% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.90%
in Dec 2025Figures in %
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024






